The National Agency for Food and Drugs Administration and Control (NAFDAC) has recently issued a public notification regarding the recall of certain lots of Cardura XL (Doxazosin), a medication used to treat hypertension and enlarged prostate. As a company committed to your health and well-being, we feel it's crucial to share this important information with our valued customers and readers.
According to NAFDAC, these specific lots are being recalled because they failed to meet impurity and degradation specifications. This quality issue could potentially affect the safety and efficacy of the medication.
The use of substandard medications can lead to serious health consequences, including:
If you are currently using Cardura XL, we strongly advise the following:
NAFDAC encourages healthcare professionals and consumers to report any adverse reactions or side effects related to the use of this product. You can report through the following channels:
This recall serves as a reminder of the importance of staying informed about the medications we use. Always purchase your medications from authorized suppliers and be cautious of counterfeit or substandard products.
For any questions or concerns, please consult with your healthcare provider or pharmacist.
Stay safe and healthy!
Disclaimer: This is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for medical concerns.